Features

New line of attack on a dreaded disease

New line of attack on a dreaded disease

In honor of a friend fighting a brain tumor, Turkish financier’s multimillion-dollar gift funds genomic analysis of deadly glioblastomas

Few diseases are as feared, or as deadly, as glioblastoma multiforme (GBM), the most aggressive and most common form of brain cancer, which accounts for about 60 percent of all brain tumors diagnosed in the United States each year. Over the past five years, improvements in radiotherapy and surgical techniques, and the advent of drugs that block blood vessel formation in tumors have significantly increased survival time in patients with GBM. But despite these advances, on average these patients...

Read more...

Kavli neuroscience institute to cast an even wider scientific net

Kavli neuroscience institute to cast an even wider scientific net

Building upon a grant made in 2003 that established the Kavli Institute for Neuroscience at Yale, The Kavli Foundation has announced that it will contribute additional endowment funds to diversify and strengthen the institute’s interdisciplinary brain research.

Since the beginnings of neuroscience research, Yale researchers have excelled in the quest to understand the fundamental mechanisms of how the human brain...

Read more...

In life and work, alumnus touched countless hearts

In life and work, alumnus touched countless hearts

There could be no greater gratification for a physician–scientist than seeing the fruits of his or her own research become an integral part of medical practice, providing patients with a better treatment than any that had existed before.

The late Donald S. Baim, M.D., a member of...

Read more...